CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine. Follicular lymphoma is a typically slow ...
The updated risk evaluation and mitigation strategies for autologous CAR T-cell therapy removed requirements for training and ...
Chinese researchers have developed a new version of a cell therapy used to treat blood cancers, and they say it has potential as a versatile and much cheaper option than those currently being used.
CHICAGO, July 22, 2024 /PRNewswire/ -- The global CAR T-cell Therapy Market is expected to grow from USD 5.5 billion in 2024 to USD 29.0 billion by 2029, at a CAGR of 39.6%. This growth is driven ...
The CAR-NK program, dubbed CB-020, was an induced pluripotent stem cell (iPSC)-derived allogeneic anti-ROR 1 cell therapy aimed at solid tumors. Caribou already revealed in March that it had ...
One morning at the end of April 2023, Marcela Maus, a cancer researcher at Mass General in Boston, got a call from her ...
Californian start-up Caribou Biosciences (Nasdaq: CRBU) has announced significant workforce reductions, cutting approximately ...
We earn a commission from partner links on Forbes Home. Commissions do not affect our editors' opinions or evaluations. Whether moving cross-country or heading to a winter home, shipping your car ...
A car is an expensive purchase, but choosing the right lender can save you thousands of dollars in interest charges and fees. Plus, you want your car shopping experience to be easy and transparent ...
Auto insurance is a necessity for many Americans. But it can also be quite costly, with the average car owner spending just over $2,299 a year for full coverage, or $637 for minimum coverage in ...
Although new-car prices have come down slightly over the last year, they’re still averaging about 30 percent higher than before the pandemic. That, plus high interest rates, can still make ...
Gilead Sciences, Inc. excels in biotechnology with a focus on innovative medicines for life-threatening diseases such as HIV, viral hepatitis, and cancer. The company is a key player in CAR T-cell ...